+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Palatin Technologies Inc (PTN) - Financial and Strategic SWOT Analysis Review

Palatin Technologies Inc (PTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Palatin Technologies Inc (Palatin) is a biopharmaceutical company. Palatin focuses on developing innovative therapeutics targeting the melanocortin receptor (MCR) system. The company's main activities involve researching and designing receptor-specific therapies, including agonists and antagonists, to address various physiological functions. Palatin's major products include treatments for obesity, male sexual dysfunction, and ocular diseases. The company has licensed a product candidate for dry eye disease to a third party and melanocortin receptor compounds for retinal diseases to Boehringer Ingelheim. Palatin's products are used in medical applications across industries such as healthcare and pharmaceuticals, targeting conditions like inflammatory and autoimmune diseases. It is also conducting a Phase 2 study for PL8177, targeting inflammatory bowel diseases, while also progressing with research for diabetic nephropathy and diabetic retinopathy. Palatin is headquartered in Cranbury, New Jersey, the US.

Palatin Technologies Inc Key Recent Developments

  • Sep 28, 2026: Palatin Technologies Reports Fiscal Year 2026 Financial Results and Business Update
  • Sep 28, 2026: Palatin Technologies, Inc. Corporate Presentation September 2026
  • Feb 17, 2026: Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
  • Nov 06, 2025: Palatin Presents Data at ObesityWeek 2025 on Melanocortin-Based Therapies for Obesity

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Palatin Technologies Inc - Key Facts
  • Palatin Technologies Inc - Key Employees
  • Palatin Technologies Inc - Key Employee Biographies
  • Palatin Technologies Inc - Major Products and Services
  • Palatin Technologies Inc - History
  • Palatin Technologies Inc - Company Statement
  • Palatin Technologies Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Palatin Technologies Inc - Business Description
  • R&D Overview
  • Palatin Technologies Inc - Corporate Strategy
  • Palatin Technologies Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Palatin Technologies Inc - Strengths
  • Palatin Technologies Inc - Weaknesses
  • Palatin Technologies Inc - Opportunities
  • Palatin Technologies Inc - Threats
  • Palatin Technologies Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Palatin Technologies Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 28, 2026: Palatin Technologies Reports Fiscal Year 2026 Financial Results and Business Update
  • Sep 28, 2026: Palatin Technologies, Inc. Corporate Presentation September 2026
  • Feb 17, 2026: Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
  • Nov 06, 2025: Palatin Presents Data at ObesityWeek 2025 on Melanocortin-Based Therapies for Obesity
  • Sep 22, 2025: Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
  • Aug 18, 2025: Boehringer Ingelheim marks retinal disease push with $327m licensing deal
  • May 09, 2025: Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025
  • Feb 13, 2025: Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update
  • Jan 28, 2025: Palatin Provides Update on Anticipated 2025 Corporate Milestones
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact Us
  • Disclaimer
List of Tables
  • Palatin Technologies Inc, Key Facts
  • Palatin Technologies Inc, Key Employees
  • Palatin Technologies Inc, Key Employee Biographies
  • Palatin Technologies Inc, Major Products and Services
  • Palatin Technologies Inc, History
  • Palatin Technologies Inc, Subsidiaries
  • Palatin Technologies Inc, Key Competitors
  • Palatin Technologies Inc, Ratios based on current share price
  • Palatin Technologies Inc, Annual Ratios
  • Palatin Technologies Inc, Interim Ratios
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Palatin Technologies Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Palatin Technologies Inc, Performance Chart (2022 - 2026)
  • Palatin Technologies Inc, Ratio Charts
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Verastem Inc
  • Talphera Inc
  • Savara Inc
  • Rhythm Pharmaceuticals Inc
  • F. Hoffmann-La Roche Ltd
  • Eton Pharmaceuticals Inc
  • Ardelyx Inc
  • Altimmune Inc
  • Allergan Unlimited Co